Company Releases Early Clinical Data For Experimental Blood Cancer Drug
<a href="https://pixabay.com/users/SarahMarciano/">SarahMarciano</a> / Pixabay

Company Releases Early Clinical Data For Experimental Blood Cancer Drug

According to a story from pm360online.com, the biopharmaceutical company miRagen Therapeutics, Inc., recently presented Phase I clinical trial data regarding the company's experimental drug cobomarsen. This data was presented at…

Continue Reading
Close Menu